AVDL - Avadel Pharmaceuticals plc (AVDL) CEO Greg Divis on Q3 2020 Results - Earnings Call Transcript

Avadel Pharmaceuticals plc (AVDL) Q3 2020 Earnings Conference Call November 09, 2020, 08:30 AM ET Company Participants Thomas McHugh - CFO Greg Divis - CEO Conference Call Participants David Amsellem - Piper Sandler Paul Matteis - Stifel Francois Brisebois - Oppenheimer Matt Kaplan - Ladenburg Presentation Operator Greetings. Welcome to Avadel Pharmaceuticals Third Quarter 2020 Earnings Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to your host Tom McHugh, CFO. Thank you, you may begin. Thomas McHugh Good morning, and thank you for joining us on our conference call. This morning, we issued our third quarter financial results news release, which can be accessed on our website www.avadel.com. As a reminder, before we begin, the following presentation includes several matters that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to

For further details see:

Avadel Pharmaceuticals plc (AVDL) CEO Greg Divis on Q3 2020 Results - Earnings Call Transcript